Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick M Sexton

Showing results (61-70 of 301) with videos related to

Pageof 31
Sort By:
Regulatory Peptides|June 15, 2010
Importance of lipid-exposed residues in transmembrane segment four for family B calcitonin receptor homo-dimerizationKaleeckal G Harikumar, Alicja M Ball, Patrick M Sexton, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 5, 2015
Endogenous allosteric modulators of G protein-coupled receptorsEmma T van der Westhuizen, Celine Valant, Patrick M Sexton, et al.
Chemical Reviews|April 5, 2016
Allostery and Biased Agonism at Class B G Protein-Coupled ReceptorsDenise Wootten, Laurence J Miller, Cassandra Koole, et al.
Nature Reviews. Molecular Cell Biology|August 15, 2018
Mechanisms of signalling and biased agonism in G protein-coupled receptorsDenise Wootten, Arthur Christopoulos, Maria Marti-Solano, et al.
Regulatory Peptides|September 22, 2007
The effects of C-terminal truncation of receptor activity modifying proteins on the induction of amylin receptor phenotype from human CTb receptorsMadhara Udawela, George Christopoulos, Maria Morfis, et al.
Molecular Pharmacology|March 15, 2006
Distinct receptor activity-modifying protein domains differentially modulate interaction with calcitonin receptorsMadhara Udawela, George Christopoulos, Nanda Tilakaratne, et al.
ACS Chemical Neuroscience|September 5, 2014
Development of a photoactivatable allosteric ligand for the m1 muscarinic acetylcholine receptorBriana J Davie, Patrick M Sexton, Ben Capuano, et al.
Progress in Molecular Biology and Translational Science|August 10, 2010
Receptor activity modifying proteins and their potential as drug targetsDenise L Wootten, John Simms, Debbie L Hay, et al.
Molecular Pharmacology|February 9, 2011
The role of transmembrane domain 3 in the actions of orthosteric, allosteric, and atypical agonists of the M4 muscarinic acetylcholine receptorKatie Leach, Anna E Davey, Christian C Felder, et al.
Drug Discovery Today|January 20, 2009
Modulating receptor function through RAMPs: can they represent drug targets in themselves?Patrick M Sexton, David R Poyner, John Simms, et al.
Pageof 31

Showing results (61-70 of 301) with videos related to

Sort By:
Pageof 31
Regulatory Peptides|June 15, 2010
Importance of lipid-exposed residues in transmembrane segment four for family B calcitonin receptor homo-dimerizationKaleeckal G Harikumar, Alicja M Ball, Patrick M Sexton, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 5, 2015
Endogenous allosteric modulators of G protein-coupled receptorsEmma T van der Westhuizen, Celine Valant, Patrick M Sexton, et al.
Chemical Reviews|April 5, 2016
Allostery and Biased Agonism at Class B G Protein-Coupled ReceptorsDenise Wootten, Laurence J Miller, Cassandra Koole, et al.
Nature Reviews. Molecular Cell Biology|August 15, 2018
Mechanisms of signalling and biased agonism in G protein-coupled receptorsDenise Wootten, Arthur Christopoulos, Maria Marti-Solano, et al.
Regulatory Peptides|September 22, 2007
The effects of C-terminal truncation of receptor activity modifying proteins on the induction of amylin receptor phenotype from human CTb receptorsMadhara Udawela, George Christopoulos, Maria Morfis, et al.
Molecular Pharmacology|March 15, 2006
Distinct receptor activity-modifying protein domains differentially modulate interaction with calcitonin receptorsMadhara Udawela, George Christopoulos, Nanda Tilakaratne, et al.
ACS Chemical Neuroscience|September 5, 2014
Development of a photoactivatable allosteric ligand for the m1 muscarinic acetylcholine receptorBriana J Davie, Patrick M Sexton, Ben Capuano, et al.
Progress in Molecular Biology and Translational Science|August 10, 2010
Receptor activity modifying proteins and their potential as drug targetsDenise L Wootten, John Simms, Debbie L Hay, et al.
Molecular Pharmacology|February 9, 2011
The role of transmembrane domain 3 in the actions of orthosteric, allosteric, and atypical agonists of the M4 muscarinic acetylcholine receptorKatie Leach, Anna E Davey, Christian C Felder, et al.
Drug Discovery Today|January 20, 2009
Modulating receptor function through RAMPs: can they represent drug targets in themselves?Patrick M Sexton, David R Poyner, John Simms, et al.
Pageof 31